Chemoinformaics analysis of Dihydroxanthyletin
| Molecular Weight | 230.263 | nRot | 0 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 17 |
| Exact Molecular Weight | 230.094 | nRing | 3 |
| Solubility: LogS | -4.919 | nHRing | 2 |
| Solubility: LogP | 3.42 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 35.1211 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.653 |
| Synth | 2.521 |
| Natural Product Likeliness | 1.279 |
| NR-PPAR-gamma | 0.055 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.696 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.673 |
| MDCK | 0.0000195 |
| BBB | 0.048 |
| PPB | 0.956158 |
| VDSS | 0.658 |
| FU | 0.048542 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.687 |
| CYP2c19-sub | 0.264 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.885 |
| CYP2d6-inh | 0.596 |
| CYP2d6-sub | 0.854 |
| CYP3a4-inh | 0.073 |
| CYP3a4-sub | 0.301 |
| CL | 10.382 |
| T12 | 0.24 |
| hERG | 0.025 |
| Ames | 0.031 |
| ROA | 0.163 |
| SkinSen | 0.081 |
| Carcinogencity | 0.852 |
| EI | 0.63 |
| Respiratory | 0.045 |
| NR-Aromatase | 0.31 |
| Antiviral | No |
| Prediction | 0.636794 |